Oruka Therapeutics, Inc. · NASDAQ:ORKA
Sandler Laura Lee sold 5,000 Oruka Therapeutics, Inc. shares (Form 4)
Traded Jul 1, 2026 · Filed Jul 1, 2026
On Jul 1, 2026, Sandler Laura Lee (Chief Operating Officer) sold 5,000 Oruka Therapeutics, Inc. shares at an average US$94.42 for US$472K under a trading plan, leaving 236,384 shares. Filed Jul 1, 2026 (Form 4).
- Sold
- 5,000 shares
- Price
- US$94.42 average (US$93.85 to US$95.47)
- Value
- US$472K
- Holding after
- 236,384 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | Option exercise | 5,000 | US$7.80 | 241,384 | Direct |
| Jul 1, 2026 | Common Stock | Sale | 2,237 | US$93.85 | 239,147 | Direct |
| Jul 1, 2026 | Common Stock | Sale | 2,263 | US$94.75 | 236,884 | Direct |
| Jul 1, 2026 | Common Stock | Sale | 500 | US$95.47 | 236,384 | Direct |
Source
Related
- Oruka Therapeutics, Inc.
- Sandler Laura Lee
- Oruka Therapeutics, Inc. shareholders
- Form 4 · Sandler Laura Lee · Sep 15, 2026
- Form 4 · Sandler Laura Lee · Sep 1, 2026
- Form 4 · Sandler Laura Lee · Jun 15, 2026
- Form 4 · Sandler Laura Lee · May 1, 2026
- Form 4 · Quinlan Paul T · Oct 20, 2026
- Form 4 · Goncalves Joana · Oct 15, 2026
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Klein Lawrence Otto · Oct 2, 2026
- Form 4 · Quinlan Paul T · Sep 21, 2026